Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
GSK plc brands
Dutasteride/tamsulosin
Другие языки:

    Dutasteride/tamsulosin

    Подписчиков: 0, рейтинг: 0
    Dutasteride/tamsulosin
    Combination of
    Dutasteride 5α-Reductase inhibitor
    Tamsulosin Alpha-1 blocker
    Clinical data
    Trade names Jalyn
    AHFS/Drugs.com Professional Drug Facts
    License data
    Pregnancy
    category
    • AU: X (High risk)
    Routes of
    administration    		 By mouth
    ATC code
    Legal status
    Legal status
    Identifiers
    CAS Number
    KEGG

    Dutasteride/tamsulosin, sold under the brand name Jalyn among others, is a medication produced by GlaxoSmithKline for the treatment of adult male symptomatic benign prostatic hyperplasia (BPH). It is a combination of two previously existing medications: dutasteride, brand name Avodart, and tamsulosin, brand name Flomax. It contains 0.5 mg of dutasteride and 0.4 mg of tamsulosin hydrochloride.

    Jalyn was the result of the CombAT (Combination of Avodart and Tamsulosin) trial of 2008. It was approved by the U.S. Food and Drug Administration (FDA) on June 14, 2010. In June 2011, the FDA approved a label change to warn of "Increased Risk of High-grade Prostate Cancer" from Jalyn.

    External links


    Новое сообщение